Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
226.2 USD | -0.61% | -6.33% | -4.37% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.37% | 11.68B | |
-2.37% | 41.35B | |
+42.15% | 40.38B | |
+1.21% | 39.05B | |
-14.19% | 26.67B | |
+1.49% | 24.07B | |
-24.99% | 18.36B | |
+20.27% | 11.6B | |
+7.62% | 11.15B | |
-19.67% | 9.78B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International : JPMorgan Adjusts Price Target on Charles River Laboratories International to $390 From $375, Keeps Overweight Rating